Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer
NCT01794312 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 152
Last updated 2019-10-23
Summary
The purpose of this study is to assess the efficacy and safety of T4020 versus vehicle.
Conditions
- Keratitis
- Corneal Ulcer
Interventions
- DEVICE
-
T4020
- DEVICE
-
Vehicle
Sponsors & Collaborators
-
Laboratoires Thea
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2017-12-19
- Completion
- 2017-12-19
Countries
- France
Study Locations
More Related Trials
-
Intravitreal Anti-vascular Endothelial Growth Factor Administration and Its Influence on Vitreomacular Interface- and Retinal Morphology in Eyes With Neovascular Age-related Macular Degeneration
NCT03680326 ·Status: COMPLETED
-
Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy
NCT06899529 ·Status: RECRUITING ·Phase: NA
-
Strategies for Management of Corneal Neovascularisation
NCT02594423 ·Status: UNKNOWN ·Phase: PHASE4
-
Bevacizumab Intravitreal for Myopic Choroidal Neovascularization
NCT00797992 ·Status: COMPLETED ·Phase: PHASE4
-
Intravitreal Conbercept Injection in Patients With Myopic Choroidal Neovascularization
NCT03971162 ·Status: COMPLETED ·Phase: NA
-
TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration
NCT00260403 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD
NCT00684853 ·Status: UNKNOWN ·Phase: PHASE2
-
Ocular Discomfort Assessment After Intravitreal Injections
NCT02806830 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia
NCT00967850 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy
NCT00383812 ·Status: UNKNOWN ·Phase: NA
-
Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD
NCT00370539 ·Status: UNKNOWN ·Phase: PHASE3
-
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
NCT01012973 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Modification of the Retinal Nerve Fiber Layer in Patients Treated With Intravitreous Injection of Anti-VEGF
NCT02876198 ·Status: COMPLETED
-
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
NCT01724385 ·Status: COMPLETED ·Phase: PHASE4
-
Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation
NCT04234932 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Comparison of Subconjuctival Versus Topical Bevacizumab as Adjunct Therapy to Trabeculectomy
NCT01425112 ·Status: COMPLETED ·Phase: NA
-
Combination Therapy for Neovascular Age Related Macular Degeneration
NCT00447031 ·Status: WITHDRAWN ·Phase: NA
-
Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)?
NCT00813514 ·Status: WITHDRAWN ·Phase: NA
-
Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study
NCT02015351 ·Status: COMPLETED ·Phase: NA
-
Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision
NCT01053858 ·Status: COMPLETED ·Phase: NA
-
Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration
NCT00347399 ·Status: TERMINATED ·Phase: PHASE2
-
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
NCT00943072 ·Status: COMPLETED ·Phase: PHASE3
-
The Effectiveness of Intravitreal Avastin Injection for CRVO
NCT01678248 ·Status: UNKNOWN
-
Medico-economic Evaluation of Anti-VEGF Treatments in the Treatment of naïve Age-related Macular Degeneration (AMD): a Model Adapted to the French Context
NCT03577041 ·Status: UNKNOWN
-
Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment
NCT02287298 ·Status: COMPLETED